home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  Early Drug Target Validation  
  April 02, 2001

Cell and Molecular Biology / Anatomy

 
     
  Vision in Business, Forum Park Hotel, Geneva, Switzerland
21/05/01-22/05/01


-Pfizer perspective: Methods to select the best targets to validate
-How GlaxoSmithkline use transgenic knockouts for evidence based target selection and validation
-Using in-vivo mammalian data to speed your target validation process
-Using differential gene expression analysis to identify potential targets
-Antisense and functional genomics: real working examples in tissue culture and in-vivo
 
 
Organized by: Vision in Business
Invited Speakers: Deltagen
Cambridge Drug Discovery
Serono
GlaxoSmithKline
Pharmagene
AstraZeneca
Pharmagene PLC
Pfizer
 
Deadline for Abstracts: 22/05/01
 
Registration: 21/05/01 0845 Registration and coffee
E-mail: postmaster2@visioninbusiness.com
 
  Posted by:   Emma Baker  
Host: mail.visioninbusiness.com
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.